Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Shavano Park, Texas Clinical Trials

A listing of Shavano Park, Texas clinical trials actively recruiting patient volunteers.

RESULTS

Found (12) clinical trials

An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) for up to 52 Weeks.

This study is designed to evaluate the safety, tolerability, and efficacy of vibegron administered once daily in patients with OAB for up to 52 weeks.

Phase

3.92 miles

Learn More »

A Trial of Linaclotide 290 g in Patients With Irritable Bowel Syndrome With Constipation

12 week treatment period followed by 4-week Randomized Withdrawal (RW) Period.

Phase

5.67 miles

Learn More »

A Study to Evaluate the Safety Tolerability and Immunogenicity of V114 Followed by PNEUMOVAX 23 in Healthy Adults 50 Years of Age or Older (V114-016/PNEU-PATH)

This study is designed 1) to evaluate the safety, tolerability, and immunogenicity of V114 and Prevnar 13 in healthy adults 50 years of age or older, 2) to describe the safety of sequential administration of V114 or Prevnar 13 followed by PNEUMOVAX23, and 3) to evaluate the immune responses to ...

Phase

5.67 miles

Learn More »

Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy

This protocol (NLG0705) provides a mechanism for the 15-year follow-up period that the FDA requires for all participants in gene transfer protocols and assures that adequate follow-up can be maintained for subjects who have received at least one dose of algenpantucel-L.

Phase N/A

5.67 miles

Learn More »

Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)

The purpose of this study is to evaluate the efficacy and safety of SHP647 in inducing clinical remission and endoscopic response in participants with moderate to severe Crohn's Disease.

Phase

5.67 miles

Learn More »

Clinical Trials of Texas, Inc. is conducting a research study of an investigational medication for participants. Qualified participants receive study-related medical care from a board-certified physician, study medications, supplies and exams.

Phase N/A

5.67 miles

Learn More »

Clinical Trials of Texas, Inc. is conducting a research study, for women with symptoms of a UTI.

Phase N/A

5.67 miles

Learn More »

You may have urge incontinence if you have a strong, sudden need to urinate. If you are a woman between 18 to 80 years of age and are experiencing symptoms of urge urinary incontinence or have been diagnosed by your physician, you may qualify for a new research study at ...

Phase N/A

5.67 miles

Learn More »

Study of REGN4659 in Combination With Cemiplimab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

The objective of this trial is to study REGN4659 and cemiplimab in treatment-experienced, non-small cell lung cancer (NSCLC) patients. There are 2 phases of this study: a dose escalation phase and a dose expansion phase.

Phase

5.67 miles

Learn More »

Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive HER2-negative Advanced Breast Cancer

The purpose of this study is to assess the efficacy of LEE011, as measured by progression free survival (PFS), in premenopausal women with HR positive, HER2 negative advanced breast cancer

Phase

5.67 miles

Learn More »